ArticlePloS one2024
Effects of genetically modified soybean on physiological variables and gut microbiota of Sprague-Dawley rats.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Soybean is an important source of food and feed. To keep weeds out of soybean it is often genetically modified. The goal of the current study was to evaluate the effects of a diet containing 70% GM soybean on Sprague-Dawley rats. Two groups of rats were fed GM and non-GM soybeans for a period of 120 days, and their body weight, hematology and serum biochemistry were compared. In addition, the effect of the consumption of GM soybean on identified intestinal microbiota and antibiotic resistance was compared with the effect of the consumption of non-GM soybean. Total bacteria and six types of bacteria shared by humans and rats were detected by q-PCR. The results showed that the consumption of GM soybean did not result in any significant changes in body weight, hematology and serum biochemistry. The results of q-PCR indicated that compared with the consumption of non-GM soybeans, the consumption of GM soybean did not have a comparable effect on the abundance of total bacteria, namely Bifidobacterium group, Clostridium perfringens subgroup, Escherichia coli, Lactobacillus group, and the Bacteroides-Prevotella group. The results of antibiogram showed that the consumption of GM soybean did not change the resistance of E.coli, although it changed the resistance of E. faecalis against erythromycin (the GM group was significantly less resistant than non-GM group). Overall, the study indicated that the consumption of GM soybean did not exhibit adverse effects on physiological variables and gut microbiota of rats. However, the obtained antibiogram results indicated that it is necessary to further investigate the antibiotic resistance of the gut microbiota when GM food is consumed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.